| Tresiba (insulin degludec) / Novo Nordisk |
NCT01865279: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec |
|
|
| Completed | 1 | 64 | Europe | insulin degludec, placebo, isophane human insulin | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 04/06 | 04/06 | | |
NCT01865292: Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes |
|
|
| Completed | 1 | 40 | Europe | insulin degludec, insulin glargine | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 11/06 | 11/06 | | |
NCT01865318: Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 36 | Europe | insulin degludec | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 01/07 | 01/07 | | |
NCT01868529: Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus |
|
|
| Completed | 1 | 63 | Europe | insulin degludec, insulin glargine | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 06/08 | 06/08 | | |
NCT00964964: A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics |
|
|
| Completed | 1 | 18 | Europe | insulin degludec, placebo | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 09/09 | 09/09 | | |
NCT00961324: A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 54 | Europe | insulin degludec, insulin glargine | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 10/09 | 10/09 | | |
NCT00964418: A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 27 | Europe | insulin degludec, insulin glargine | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 11/09 | 11/09 | | |
|
NCT01002768: Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics |
|
|
| Completed | 1 | 28 | Europe | insulin degludec, insulin glargine | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 03/10 | 03/10 | | |
NCT01030926 / 2008-008306-43: A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 Diabetes |
|
|
| Completed | 1 | 39 | Europe | insulin degludec, insulin glargine | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 05/10 | 05/10 | | |
NCT01076634: Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 33 | Europe | insulin degludec | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 07/10 | 07/10 | | |
NCT01114542: A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 66 | Europe | insulin degludec, insulin glargine | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 08/10 | 08/10 | | |
|
NCT01135927: A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes |
|
|
| Completed | 1 | 22 | Japan | insulin degludec, insulin detemir | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 10/10 | 10/10 | | |
NCT01704417: A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin Glargine |
|
|
| Completed | 1 | 40 | Europe | insulin degludec, insulin glargine | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 03/13 | 03/13 | | |
NCT02536859: Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus |
|
|
| Completed | 1 | 60 | Europe | insulin degludec, insulin glargine | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 1 | 04/16 | 04/16 | | |
